Q&A With Lee Helman, MD, on New Cancer Targets and Therapeutics
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
Research has fueled significant progress against breast cancer—the overall five-year survival rate for female breast cancer patients in the...
Cancer research has led to great progress in cancer prevention, detection, diagnosis, and treatment, improving and saving countless lives....
From Oct. 9-12, the American Association for Cancer Research will host its first major conference in China: New Horizons...
If you are someone who would bet all your chips on helping people not get cancer in the first...
Rarely do investigators in two distinct fields of cancer research have the time to come together for an evening...
The public craves solid health information, and knowledge about cancer research and treatment is vital to their well-being. The...
In the coming months, we will share posts from advocates who participated in the AACR’s Scientist↔Survivor Program at the...
Today’s early-career investigators are the future of cancer research and progress in the quest to prevent and cure cancer....